Search by Drug Name or NDC
NDC 00069-0338-01 Revatio 0.8 mg/mL Details
Revatio 0.8 mg/mL
Revatio is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PFIZER LABORATORIES DIV PFIZER INC. The primary component is SILDENAFIL CITRATE.
Product Information
| NDC | 00069-0338 |
|---|---|
| Product ID | 0069-0338_c74907a0-9727-4683-8aef-d2312b3afa6b |
| Associated GPIs | 40143060102020 |
| GCN Sequence Number | 066092 |
| GCN Sequence Number Description | sildenafil citrate VIAL 10 MG/12.5 INTRAVEN |
| HIC3 | B1D |
| HIC3 Description | PULM.ANTI-HTN,SEL.C-GMP PHOSPHODIESTERASE T5 INHIB |
| GCN | 28273 |
| HICL Sequence Number | 018084 |
| HICL Sequence Number Description | SILDENAFIL CITRATE |
| Brand/Generic | Brand |
| Proprietary Name | Revatio |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | sildenafil citrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.8 |
| Active Ingredient Units | mg/mL |
| Substance Name | SILDENAFIL CITRATE |
| Labeler Name | PFIZER LABORATORIES DIV PFIZER INC |
| Pharmaceutical Class | Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022473 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00069-0338-01 (00069033801)
| NDC Package Code | 0069-0338-01 |
|---|---|
| Billing NDC | 00069033801 |
| Package | 1 VIAL in 1 CARTON (0069-0338-01) / 12.5 mL in 1 VIAL |
| Marketing Start Date | 2009-11-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |